Jasper Therapeutics, Inc. (JSPR) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $4.15M | -93.3% |
| 2024 | $61.67M | -21.4% |
| 2023 | $78.44M | +118.0% |
| 2022 | $35.99M | -48.2% |
| 2021 | $69.52M | +297.9% |
| 2020 | -$35.13M | -642.1% |
| 2019 | -$4.73M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $4.15M | -93.3% |
| 2024 | $61.67M | -21.4% |
| 2023 | $78.44M | +118.0% |
| 2022 | $35.99M | -48.2% |
| 2021 | $69.52M | +297.9% |
| 2020 | -$35.13M | -642.1% |
| 2019 | -$4.73M | — |